Markets
AbCellera Biologics Inc. (ABCL)
ABCLNASDAQ-GSBiotechnology: Pharmaceutical Preparations
$12.94
+1.06 (+8.93%) today
Closed, Nov 9, 4:00 PM ET
+8.93% 1D
- Market cap
- $4.05bn
- P/E
- –
- EPS, last 4 quarters
- $-0.5400
- Dividend yield
- –
- Day range
- –
- 52-week range
- $2.75 to $15.02
- Average volume
- 4.36m
- Previous close
- $11.88
Analysts
7 coveringBuy6 buy, 1 hold, 0 sell
Targets a year out average $19.86, +53.5% from here
$13.00now $12.94$30.00
Earnings
next estimate $-0.1800Next report
Sep 2025
-11.8%
Dec 2025
+83.3%
Mar 2026
+36.4%
Jun 2026
-5.9%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $8.96m | $44.85m | $8.31m | $4.05m |
| Gross profit | $8.96m | $44.85m | $8.31m | $4.05m |
| Operating income | -$76.28m | -$28.58m | -$57.52m | -$62.78m |
| Net income | -$57.12m | -$8.95m | -$43.16m | -$55.43m |
Last four quarters: revenue $66.17m, margin -248.8%, free cash flow -$119.67m
News
8 latest- AbCellera Biologics Inc. Reports Q3 2026 Business Results and $200 million OfferingFintel · 44 minutes ago
- AbCellera Biologics Inc Q3 Loss Decreases RTTNews · 1 hour ago
- AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue EstimatesZacks · 7 hours ago
- Janux Therapeutics, Inc. (JANX) Reports Q3 Loss, Beats Revenue EstimatesZacks · 4 days ago
- Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Misses Revenue EstimatesZacks · 5 days ago
- Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue EstimatesZacks · 6 days ago
- Nurix Therapeutics, Inc. (NRIX) Q3 Earnings and Revenues Surpass EstimatesZacks · Oct 12, 2026
- Biotech Stocks At 52-Week Highs - IOVA +31%, XERS, GRAL, ABCL, SGHT RTTNews · Sep 30, 2026
The company
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women's health, immunology, oncology, and more.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- abcellera.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.